CIC
SRDX

Cornercap Investment Counsel’s Surmodics SRDX Stock Holding History

Cornercap Investment Counsel’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,317
Closed -$1.1M – 602
2021
Q2 		$1.1M Buy
+20,317
New +$1.11M 0.12% 312

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Cornercap Investment Counsel's SRDX Position: Q3 2021 in Review

Cornercap Investment Counsel sold out of Surmodics (SRDX) in Q3 2021, closing a stake of 20,317 shares — an estimated $1.1M sold.

Cornercap Investment Counsel first reported a position in SRDX in Q2 2021 and held it in 1 quarter. The position peaked at $1.1M in Q2 2021. 152 funds tracked by Wall St. Rank hold SRDX as of Q3 2021.

  • Cornercap Investment Counsel reported no remaining Surmodics position as of Q3 2021 after selling out during the quarter.
  • Cornercap Investment Counsel sold 20,317 Surmodics shares in Q3 2021, an estimated $1.1M.
  • Cornercap Investment Counsel first reported a position in Surmodics in Q2 2021 and held it in 1 quarter.
  • Cornercap Investment Counsel's Surmodics position peaked at $1.1M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Surmodics as of Q3 2021.

Based on Cornercap Investment Counsel's 13F filing for Q3 2021, filed 15 Nov 2021.